| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |